Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.52 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | F2R | P25116 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.45 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.45 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29466485 | 1.00 | NPC1 (0.52) | NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL5798650 | 0.93 | SMN1; SMN2 (0.48) | NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL17297757 | 0.84 | ALDH1A1 (0.43) | NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL5109153 | 0.82 | KMT2A (0.45) | NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL1188598 | 0.82 | G6PD (0.39) | NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL1873518 | 0.81 | KMT2A (0.41) | NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL279655 | 0.81 | ALDH1A1 (0.53) | SMN1; SMN2ALDH1A1KMT2AMEN1HPGD | |
| SCHEMBL6469935 | 0.79 | ALDH1A1 (0.40) | NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL30779705 | 0.79 | THRB (0.41) | NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL1854505 | 0.79 | THRB (0.41) | NPC1RAB9ASMN1; SMN2ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115109759-B | Carbonyl reductase LsCR mutant, engineering bacterium and application thereof in preparation of chiral alcohol by asymmetric reduction of carbonyl compound | 浙江工业大学 | 2024-05-03 | — | — | CN | claimed |
| CN-111065744-B | Method for producing chiral amines | 威妥有限公司 | 2024-05-03 | — | — | CN | claimed |
| US-11925630-B1 | 6′-(2-bromophenyl)-2′-methoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound | King Faisal University (SA) | 2024-03-12 | — | — | US | claimed |
| WO-2024046712-A1 | METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE | Forschungszentrum Jülich GmbH (DE) | 2024-03-07 | — | — | WO | claimed |
| US-11919861-B1 | 6′-(2-bromophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound | King Faisal University (SA) | 2024-03-05 | — | — | US | claimed |
| EP-4175045-B1 | COATED SEPARATOR WITH HIGH HEAT RESISTANCE AND HIGH PEEL STRENGTH AND PREPARATION METHOD THEREOF | JIANGSU HORIZON NEW ENERGY TECH CO LTD (CN) | 2023-10-11 | — | — | EP | claimed |
| CN-113991250-B | High-heat-resistance high-peel strength coated diaphragm and preparation method thereof | 江苏厚生新能源科技有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-116178365-A | Berberine hydrochloride derivative and preparation method and application thereof | 常州大学 | 2023-05-30 | — | — | CN | claimed |
| EP-4175045-A1 | COATED SEPARATOR WITH HIGH HEAT RESISTANCE AND HIGH PEEL STRENGTH AND PREPARATION METHOD THEREOF | Jiangsu Horizon New Energy Tech Co., Ltd (CN) | 2023-05-03 | — | — | EP | claimed |
| CN-115925527-A | Method for preparing alpha-diaryl methyl substituted ketone compound | 湖南理工学院 | 2023-04-07 | — | — | CN | claimed |
| WO-2009050366-A2 | ARYLAMINE SYNTHESIS METHOD | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2009-04-23 | — | — | WO | claimed |
| EP-1868604-A2 | REGULATION OF PROTEIN SYNTHESIS BY INHIBITION OF EIF4E-EIF4G INTERACTION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-12-26 | — | — | EP | claimed |
| WO-2006078942-A2 | REGULATION OF PROTEIN SYNTHESIS BY INHIBITION OF EIF4E-EIF4G INTERACTION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2006-07-27 | — | — | WO | claimed |
| EP-0912467-B1 | ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE | RHODIA CHIMIE SA (FR) | 2002-04-24 | — | — | EP | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0912467-A1 | ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE | RHODIA CHIMIE (FR) | 1999-05-06 | — | — | EP | claimed |
| WO-1998000375-A1 | ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE | RHODIA CHIMIE (FR) | 1998-01-08 | — | — | WO | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-4048036-A | CURING, PHOTOINITIATOR | PPG INDUSTRIES, INC. (US) | 1977-09-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11925630-B1 | 6′-(2-bromophenyl)-2′-methoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound | GPX4, GPX1, CAT | NPC1 1715/4885RAB9A 3176/4885SMN1; SMN2 1130/4885 |
| US-11919861-B1 | 6′-(2-bromophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound | GPX4, GPX1, CAT | NPC1 1638/4885RAB9A 3173/4885SMN1; SMN2 1389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.